Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck ...

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

While Merck's shares declined by 3% over the last month, this shift aligns with the flat market performance, ...

Merck is facing an awkward encore as one of the worst-performing blue chip stocks in 2025, sliding 23.3% year-to-date.

Merck & Co took a hit on May 14, 2025, as Citigroup downgraded its rating from "Buy" to "Neutral" and slashed its price ...

and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial performance of a business entity when making investment ...

Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

Shares of Merck & Co. Inc. MRK slid 1.86% to $77.65 Thursday, on what proved to be an all-around positive trading session for ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

EARNINGS FORECAST: Merck's earnings before interest, taxes, depreciation, amortization and one-off items is forecast to come in at 1.51 billion euros, according to the consensus. The company reported ...